ArticleAlzheimer's research & therapy2020

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification.

Nicolas R Barthélemy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.